Table 1.
Patients with echocardiogram at baseline (analytic subcohort) | Patients without echocardiogram at baseline (excluded from analysis) | p-value* | |
---|---|---|---|
Number of participants (n)* | 529 | 126 | |
Demographics: | |||
Age, mean ±SD, (in years) | 69.1 ± 12.6 | 71.9 ± 12.5 | 0.07 |
Male, N (%) | 242 (45.8) | 50 (39.7) | 0.22 |
Race- Ethnicity | |||
Non-Hispanic White, N (%) | 96 (18.1) | 28 (22.2) | ref |
Non-Hispanic Black, N (%) | 135 (25.5) | 46 (36.5) | 0.57 |
Hispanic, N (%) | 286 (54.1) | 50 (39.7) | 0.05 |
Risk factors and medical history (%): | |||
Hypertension | 442 (83.6) | 104 (82.5) | 0.78 |
Diabetes mellitus | 237 (44.8) | 58 (46.0) | 0.80 |
Congestive heart failure | 96 (18.2) | 30 (23.8) | 0.15 |
Atrial fibrillation | 97 (17.8) | 25 (19.8) | 0.59 |
Current smoking | 108 (20.5) | 24 (19.1) | 0.71 |
History of hypercholesterolemia | 265 (50.1) | 64 (50.8) | 0.89 |
Stroke etiologic subtypes, N (%) | |||
Atherosclerotic | 88 (16.6) | 12 (9.5) | 0.05 |
Lacunar | 129 (24.4) | 23 (18.3) | 0.14 |
Cardioembolic | 105 (19.7) | 22 (17.5) | 0.54 |
Cryptogenic | 193 (36.5) | 63 (50.0) | 0.01 |
Recurrent ischemic stroke, (N) % | 65 (12.3) | 16 (12.7) | 0.9 |
Follow-up time median (inter quartile range), (in year) | 4.0 (1.3 – 5.0) | 3.0 (0.9 – 5.0) | 0.18 |
Kruskal-Wallis test for continuous variables and chi-square with 1DF test for categorical variables were used.